Correlation Between Mereo BioPharma and Cairo Communication

Can any of the company-specific risk be diversified away by investing in both Mereo BioPharma and Cairo Communication at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mereo BioPharma and Cairo Communication into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Mereo BioPharma Group and Cairo Communication SpA, you can compare the effects of market volatilities on Mereo BioPharma and Cairo Communication and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mereo BioPharma with a short position of Cairo Communication. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mereo BioPharma and Cairo Communication.

Diversification Opportunities for Mereo BioPharma and Cairo Communication

-0.55

Correlation Coefficient

Mereo BioPharma  Cairo Communication

Excellent diversification

The 3 months correlation between Mereo and Cairo is -0.55. Overlapping area represents the amount of risk that can be diversified away by holding Mereo BioPharma Group and Cairo Communication SpA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cairo Communication SpA and Mereo BioPharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mereo BioPharma Group are associated (or correlated) with Cairo Communication. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cairo Communication SpA has no effect on the direction of Mereo BioPharma i.e., Mereo BioPharma and Cairo Communication go up and down completely randomly.

Pair Corralation between Mereo BioPharma and Cairo Communication

Assuming the 90 days trading horizon Mereo BioPharma Group is expected to generate 3.67 times more return on investment than Cairo Communication. However, Mereo BioPharma is 3.67 times more volatile than Cairo Communication SpA. It trades about 0.03 of its potential returns per unit of risk. Cairo Communication SpA is currently generating about -0.02 per unit of risk. If you would invest  375.00  in Mereo BioPharma Group on October 10, 2024 and sell it today you would earn a total of  1.00  from holding Mereo BioPharma Group or generate 0.27% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	95.0%
Values	Daily Returns

Mereo BioPharma Group  vs.  Cairo Communication SpA

Mereo BioPharma Group

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Mereo BioPharma Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Mereo BioPharma is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Cairo Communication SpA

Risk-Adjusted Performance

11 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Cairo Communication SpA are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Cairo Communication unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Mereo BioPharma and Cairo Communication

The main advantage of trading using opposite Mereo BioPharma and Cairo Communication positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mereo BioPharma position performs unexpectedly, Cairo Communication can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cairo Communication will offset losses from the drop in Cairo Communication's long position.

The idea behind Mereo BioPharma Group and Cairo Communication SpA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.